184 related articles for article (PubMed ID: 30515434)
1. EQUAL
Spec A; Mejia-Chew C; Powderly WG; Cornely OA
Open Forum Infect Dis; 2018 Nov; 5(11):ofy299. PubMed ID: 30515434
[TBL] [Abstract][Full Text] [Related]
2. EQUAL Fusariosis score 2021: An European Confederation of Medical Mycology score derived from current guidelines to measure QUALity of the clinical management of invasive fusariosis.
Guarana M; Nouér SA; Nucci M
Mycoses; 2021 Dec; 64(12):1542-1545. PubMed ID: 34013538
[TBL] [Abstract][Full Text] [Related]
3. EQUAL Aspergillosis Score 2018: An ECMM score derived from current guidelines to measure QUALity of the clinical management of invasive pulmonary aspergillosis.
Cornely OA; Koehler P; Arenz D; C Mellinghoff S
Mycoses; 2018 Nov; 61(11):833-836. PubMed ID: 29944740
[TBL] [Abstract][Full Text] [Related]
4. EQUAL Candida Score: An ECMM score derived from current guidelines to measure QUAlity of Clinical Candidaemia Management.
Mellinghoff SC; Hoenigl M; Koehler P; Kumar A; Lagrou K; Lass-Flörl C; Meis JF; Menon V; Rautemaa-Richardson R; Cornely OA
Mycoses; 2018 May; 61(5):326-330. PubMed ID: 29325218
[TBL] [Abstract][Full Text] [Related]
5. EQUAL Score Scedosporiosis/Lomentosporiosis 2021: a European Confederation of Medical Mycology (ECMM) tool to quantify guideline adherence.
Stemler J; Lackner M; Chen SC; Hoenigl M; Cornely OA
J Antimicrob Chemother; 2021 Dec; 77(1):253-258. PubMed ID: 34542613
[TBL] [Abstract][Full Text] [Related]
6. EQUAL Trichosporon Score 2022: an ECMM score to measure QUALity of the clinical management of invasive Trichosporon infections.
Sprute R; Bethe U; Chen SC; Cornely OA
J Antimicrob Chemother; 2022 May; 77(6):1779-1784. PubMed ID: 35325146
[TBL] [Abstract][Full Text] [Related]
7. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
[TBL] [Abstract][Full Text] [Related]
8. European confederation of medical mycology expert consult-An ECMM excellence center initiative.
Koehler P; Denis B; Denning DW; Gangneux JP; Hoenigl M; Kontoyiannis DP; Krause R; Lagrou K; Lass-Flörl C; Maertens J; Mareković I; Meis JF; Molina JM; Pleško S; Prattes J; Rath PM; Rautemaa-Richardson R; Richardson M; Segal E; Seidel D; Spriet I; Steinmann J; Verweij PE; Cornely OA;
Mycoses; 2020 Jun; 63(6):566-572. PubMed ID: 32181546
[TBL] [Abstract][Full Text] [Related]
9. Analyzing candidemia guideline adherence identifies opportunities for antifungal stewardship.
Mellinghoff SC; Hartmann P; Cornely FB; Knauth L; Köhler F; Köhler P; Krause C; Kronenberg C; Kranz SL; Menon V; Müller H; Naendrup JH; Pützfeld S; Ronge A; Rutz J; Seidel D; Wisplinghoff H; Cornely OA
Eur J Clin Microbiol Infect Dis; 2018 Aug; 37(8):1563-1571. PubMed ID: 29948362
[TBL] [Abstract][Full Text] [Related]
10. Cryptococcosis in the acquired immunodeficiency syndrome.
Kovacs JA; Kovacs AA; Polis M; Wright WC; Gill VJ; Tuazon CU; Gelmann EP; Lane HC; Longfield R; Overturf G
Ann Intern Med; 1985 Oct; 103(4):533-8. PubMed ID: 3898951
[TBL] [Abstract][Full Text] [Related]
11. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
Vechi HT; Theodoro RC; de Oliveira AL; Gomes RMODS; Soares RDA; Freire MG; Bay MB
BMC Infect Dis; 2019 Mar; 19(1):220. PubMed ID: 30832607
[TBL] [Abstract][Full Text] [Related]
12. [Cryptococcosis].
Yoshida K; Shoji H; Niki Y
Nihon Rinsho; 2008 Dec; 66(12):2350-5. PubMed ID: 19069104
[TBL] [Abstract][Full Text] [Related]
13. Cryptococcosis in an Infectious Diseases Hospital of Buenos Aires, Argentina. Revision of 2041 cases: Diagnosis, clinical features and therapeutics.
Arechavala A; Negroni R; Messina F; Romero M; Marín E; Depardo R; Walker L; Santiso G
Rev Iberoam Micol; 2018; 35(1):1-10. PubMed ID: 29129578
[TBL] [Abstract][Full Text] [Related]
14. [Lethal meningeal encephalitis from Cryptococcus neoformans var. neoformans in a girl without serious immunodeficiency].
Wendisch J; Blaschke-Hellmessen R; Kaulen F; Schwarze R; Kabus M
Mycoses; 1996; 39 Suppl 1():97-101. PubMed ID: 8767279
[TBL] [Abstract][Full Text] [Related]
15. Management of candidaemia with reference to the European confederation of medical mycology quality indicators.
Nemer S; Imtiaz T; Varikkara M; Collier A; Bal AM
Infect Dis (Lond); 2019 Jul; 51(7):527-533. PubMed ID: 31081411
[No Abstract] [Full Text] [Related]
16. Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology.
Koehler P; Mellinghoff SC; Lagrou K; Alanio A; Arenz D; Hoenigl M; Koehler FC; Lass-Flörl C; Meis JF; Richardson M; Cornely OA
J Antimicrob Chemother; 2019 Jun; 74(6):1704-1712. PubMed ID: 30770712
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
Schwarz P; Dromer F; Lortholary O; Dannaoui E
Antimicrob Agents Chemother; 2006 Jan; 50(1):113-20. PubMed ID: 16377675
[TBL] [Abstract][Full Text] [Related]
18. Clinical diversity of invasive cryptococcosis in AIDS patients from central China: report of two cases with review of literature.
Zhang Y; Cooper B; Gui X; Sherer R; Cao Q
BMC Infect Dis; 2019 Nov; 19(1):1003. PubMed ID: 31775716
[TBL] [Abstract][Full Text] [Related]
19. New Insights Into Cryptococcus Spp. Biology and Cryptococcal Meningitis.
Temfack E; Boyer-Chammard T; Lawrence D; Delliere S; Loyse A; Lanternier F; Alanio A; Lortholary O
Curr Neurol Neurosci Rep; 2019 Oct; 19(10):81. PubMed ID: 31673881
[TBL] [Abstract][Full Text] [Related]
20. Integrated therapy for HIV and cryptococcosis.
Srichatrapimuk S; Sungkanuparph S
AIDS Res Ther; 2016 Nov; 13(1):42. PubMed ID: 27906037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
